SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Product Information [Line Items]
Antidilutive shares excluded from computation of diluted earnings per share	1,050,144	2,194,079
Revenue	$ 4,031,719	$ 4,227,856
Trade Account Receivables | Customer #1
Product Information [Line Items]
Receivables, concentration	$ 738,706		$ 859,334
Concentration risk	61.40%		57.00%
Trade Account Receivables | Customer #2
Product Information [Line Items]
Receivables, concentration	$ 223,604		$ 255,136
Concentration risk	18.60%		16.90%
Sales Revenue | Customer #1
Product Information [Line Items]
Concentration risk	56.00%	57.50%
Revenue	$ 2,258,114	$ 2,431,569
Sales Revenue | Customer #2
Product Information [Line Items]
Concentration risk	17.80%	21.70%
Revenue	$ 717,577	$ 915,837